ArticleCureus2025
Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes simplex virus type 2 (HSV-2) is a chronic sexually transmitted infection and the leading cause of genital ulcer disease worldwide. The virus establishes lifelong latency with periodic reactivation, resulting in recurrent lesions and a substantial clinical and psychosocial burden. Moreover, HSV-2 increases susceptibility to HIV infection, underscoring its global public health relevance. We report a 27-year-old male who presented to the dermatovenereology clinic with a three-day history of painful penile ulcers following recent unprotected sexual contact. Physical examination revealed multiple irregular, lenticular ulcers with erythematous bases and crusting on the corpus penis and corona glandis. The patient was alert, afebrile, and without systemic symptoms. Due to limited diagnostic resources, confirmatory testing by polymerase chain reaction (PCR) or serology was unavailable. A clinical diagnosis of primary genital HSV-2 infection was made after excluding syphilis and lymphogranuloma venereum (LGV). Treatment with oral acyclovir, cefadroxil, and mefenamic acid, supplemented by topical gentamicin and counselling on recurrence risk and safe sexual practices, led to complete lesion resolution within 14 days and no recurrence at six-week follow-up. This case highlights the dual challenge of managing HSV-2 in resource-limited settings: the lifelong, recurrent nature of the infection and the absence of confirmatory diagnostic tools. These limitations hinder accurate case identification and contribute to the underrecognition of HSV-2 prevalence. Early clinical recognition, prompt antiviral initiation, and strengthened patient education remain essential for mitigating morbidity, preventing recurrence, and reducing transmission in low-resource environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.